Abstract
Protamine sulphate B.P. and Armeen DM16D acetate both inhibit a specific coagulative factor produced by malignant tumours. This factor aids the invasiveness of tumours, and its inhibition is known to retard tumour growth.Protamine and Armeen both had a greater effect on an implanted subcutaneous mouse tumour, Sarcoma 180, at 9° to 10°C than at 24° to 25°C.
Zusammenfassung
Sowohl Protaminsulfat als auch Armeen DM16D Acetat hemmen einen spezifischen gerinnung verursachenden Faktor, der von malignen Tumoren gebildet wird. Dieser Faktor erleichtert das infiltierende Wachstum der Tumoren und seine Hemmung verzögert es. Die Wachstumshemmung von subkutan implantierten Sarcoma 180 Tumoren durch Protamin und Armeen war grösser in Mäusen in der Kälte bei 9° bis 10°C als bei 24° bis 25°C.
Resume
Le sulfate de protamine et l'acétate d'armeen DM16D sont les inhibiteurs d'un principe coagulant spécifique produit par les tumeurs malignes. Ce principe facilite le développement et l'infiltration de la tumeur dans les tissus et son inhibition les ralentit. L'action inhibitive de la protamine et de l'armeen sur des tumeurs (Sarcoma 180) implantées sous la peau de souris fut plus efficace au froid (9° à 10°C) que par 24° à 25°C.
Similar content being viewed by others
References
BOGGUST, W.A., O'BRIEN, D.J., O'MEARA, R.A.Q. and THORNES, R.D. (1963): The coagulative factors of normal human and human cancer tissue. Irish J.Med.Sci., 447: 131–144.
GLASER, E.M. and AUSTIN, J.P. (1969): Effect of protamine sulphate and environmental temperature on mouse sarcoma 180. Nature (Lond.), 221: 87–88.
HUGHES, L.E. (1964): Treatment of malignant disease with protamine sulphate. Lancet, 1: 408–409.
KRASNOW, S. (1969): Physiological chilling as a possible factor in mortality from neoplasia. Int.J.Biometeor., 13: 87–92.
O'MEARA, R.A.Q. (1958): Coagulative properties of cancer. Irish J.Med.Sci., 394: 474–479.
O'MEARA, R.A.Q. and O'HALLORAN, M.J. (1963): Protamine derivatives in the treatment of advanced carcinoma of the breast. Lancet, ii: 613–614.
O'MEARA, R.A.Q. and THORNES, R.D. (1961): Some properties of the cancer coagulative factor. Irish J.Med.Sci., 423: 106–112.
THORNES, R.D. and O'MEARA, R.A.Q. (1961): A method of detecting and estimating inhibitors of the cancer coagulative factor. Irish J.Med.Sci., 428: 361–365.
TROMP, S.W. (1968): Psychosomatic aspects of cancer. Medical News Research Review, May 24: 7.
WRIGHT, J.E.C. (1968): Clinical trial of protamine in the treatment of malignant diseases. Brit.J.Cancer, 22: 415–421.
YOUNG, S. (1968): Effect of temperature on the production of induced mammary tumours. Nature (Lond.), 219: 1264–1265.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Austin, J.P., Glaser, E.M. Enhancement of anti-tumour effect by cooling. Int J Biometeorol 13, 183–187 (1969). https://doi.org/10.1007/BF01552739
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01552739